Dopaminergic synapse, action of dopaminergic agonists, COMT inhibitors, and MAO-B. Treatments for Parkinson's disease are aimed at increasing the level of dopamine in the synaptic cleft. (Photo by: ...
Much has been written about the subunit composition of hippocampal NMDA receptors and their differential contributions to functions ranging from learning to neurodegeneration. Although NMDA receptors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback